w 7 has been researched along with tamoxifen in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tallant, EA; Wallace, RW | 1 |
| Hayashi, T; Hidaka, H; Iguchi, A; Ishikawa, T; Kuzuya, M; Naito, M; Yamada, K | 1 |
| Grimshaw, R; Jarman, M; McCague, R; Rowlands, MG | 1 |
| Albright, KD; Christen, RD; Howell, SB; Jones, JA; McClay, EF | 1 |
| Biswas, DK; Cruz, A; Mutter, GL; Pardee, AB; Pettit, N | 1 |
| Feng, X; McDonald, JM; Zhang, L | 1 |
| Bedwell, GJ; Chen, Y; Fernandez, TF; Saad, JS; Samal, AB | 1 |
7 other study(ies) available for w 7 and tamoxifen
| Article | Year |
|---|---|
Calmodulin antagonists elevate the levels of 32P-labeled polyphosphoinositides in human platelets.
Topics: Blood Platelets; Calmodulin; Chlorpromazine; Humans; Kinetics; Perphenazine; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phosphatidylinositols; Promazine; Sulfonamides; Tamoxifen; Trifluoperazine | 1985 |
Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca(2+)-calmodulin dependent mechanism.
Topics: Amino Acid Oxidoreductases; Animals; Calcium; Calmodulin; Cerebellum; Clomiphene; Cytosol; Estradiol; Fulvestrant; Imidazoles; Neurons; Nitric Oxide Synthase; Progesterone; Rabbits; Receptors, Estrogen; Spectrometry, Fluorescence; Sulfonamides; Tamoxifen | 1994 |
Evidence that tamoxifen binds to calmodulin in a conformation different to that when binding to estrogen receptors, through structure-activity study on ring-fused analogues.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Calmodulin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Fluorescent Dyes; Molecular Conformation; Naphthalenesulfonates; Receptors, Estrogen; Structure-Activity Relationship; Sulfonamides; Swine; Tamoxifen | 1994 |
Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cells.
Topics: Antineoplastic Agents; Calmodulin; Cell Cycle; Cisplatin; Drug Resistance; Drug Synergism; Enzyme Induction; Humans; Melanoma; Protein Kinase C; Receptors, Estrogen; Sulfonamides; Tamoxifen; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1993 |
A therapeutic target for hormone-independent estrogen receptor-positive breast cancers.
Topics: Adult; Aged; Biochemistry; Biopsy; Breast Neoplasms; Calmodulin; Collodion; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estradiol; Female; Hormones; Humans; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Response Elements; Sulfonamides; Tamoxifen; Treatment Outcome; Tumor Cells, Cultured | 2001 |
The role of calmodulin in the regulation of osteoclastogenesis.
Topics: Animals; Apoptosis; Calmodulin; Cell Differentiation; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression; Gene Transfer Techniques; Glycoproteins; Mice; Mice, Inbred C57BL; Osteoclasts; Osteoporosis; Osteoprotegerin; Ovariectomy; Protein Kinase C; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Signal Transduction; Sulfonamides; Tamoxifen; Time Factors; Trifluoperazine | 2003 |
Structural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.
Topics: Animals; Biophysical Phenomena; Calmodulin; Calorimetry; Fas-Associated Death Domain Protein; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Magnetic Resonance Spectroscopy; Models, Molecular; Mutation; Protein Binding; Protein Structure, Tertiary; Rats; Recombinant Proteins; Sulfonamides; Surface Plasmon Resonance; Tamoxifen; Thermodynamics; Trifluoperazine | 2013 |